A long-acting GLP-1 receptor agonist with a cAMP-biased signalling profile. A niche tag, mostly used for mechanism questions about biased agonism and for reading early-phase data.
The phrase "food noise" is used constantly and I have never seen it defined precisely. My own experience of it was extremely specific and I would like to know what it…
Months two through six were the quietest my head has been about food since childhood. Around month seven it started coming back, and now at month nine it is maybe 40%…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I want to know whether this is a real physical effect or…
For reference: liraglutide · STEP 3. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that come…
Numbers first: REDEFINE-1 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
I can follow the basic signalling story: GLP-1 receptor is a Gs-coupled receptor, activation raises cAMP, protein kinase A does things, and in the beta cell that…
For reference: SURMOUNT-1 · survodutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The obesity pipeline is currently full of phase 2 results being quoted as though they were established magnitudes. Retatrutide at -24.2% over 48 weeks is the…
This matters because it predicts what a related molecule should do. This is one of those things that everyone repeats and nobody derives. This matters practically,…
Conditions: semaglutide · mazdutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can stop…
For reference: STEP 5 · ecnoglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
Numbers first: STEP 8 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Stated plainly: SURPASS-3 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
For reference: SURMOUNT-1 · survodutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standards